Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas

Dose Escalation study, 200 mg - 900 mg, cumulative daily dose split to be taken BID 7 times a week (\>8 hours between doses) for 3 weeks followed by 1 week of rest